Can telomerase activity be unleashed to refine prognosis within ependymoma subgroups?

Michal Zapotocky1, Vijay Ramaswamy1

  • 1Division of Haematology/Oncology, Department of Paediatrics, Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada; Department of Pediatric Hematology and Oncology, 2nd School of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic; Programme in Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada.

Neuro-Oncology
|May 19, 2017
PubMed
Abstract

No abstract available in PubMed .